Clinical Trials Directory

Trials / Conditions / Ischemic

Ischemic

14 registered clinical trials studyying Ischemic — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingBEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Ather
NCT07237308
Yonsei UniversityPhase 4
CompletedEffects of Cognitive Exercises With Sensory Motor Relearning Program on Upper Limb Function in Sub-Acute Strok
NCT06130891
Riphah International UniversityN/A
RecruitingPassive Limb Movement Study
NCT05935670
Medical College of WisconsinN/A
CompletedCognitive Multi-sensory Rehabilitation on Upper Limb Function and Fatigue in Stroke
NCT06251661
Cairo UniversityN/A
RecruitingPlatelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atheroscl
NCT05518305
University of California, Los Angeles—
CompletedEvaluation of the Impact of the Repositioning Schedule Adapted to the Risk of Pressure Ulcer of Patients in In
NCT04550182
Assistance Publique - Hôpitaux de ParisN/A
UnknownROSSETTI: Registry of Combined vs Single Thrombectomy Techniques
NCT04886687
Hospital Clinic of Barcelona—
CompletedMonitoring of NOAC Therapy: Standardizing Reference Intervals
NCT04611893
Chinese University of Hong Kong—
CompletedREal-World Analyses of Stroke - Thrombus Occlusion REtrieval
NCT04451525
Microvention-Terumo, Inc.—
UnknownRegional Strategy for Transfer for Mechanical Thrombectomy
NCT04046757
University Hospital, Montpellier—
RecruitingCoronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
NCT03479580
University Hospital, Grenoble—
UnknownExploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
NCT02643784
RenJi HospitalPhase 4
UnknownAnalysis of the Impact of the Fragility of the Over 70 Years of TIAprognosis
NCT02828488
Fondation Hôpital Saint-Joseph—
TerminatedEarly Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Card
NCT01557842
Biosense Webster, Inc.Phase 4